Day: June 20, 2025

Vancouver, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) — Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) has amended the option agreement (the “Amendment Agreement”) with Eagle Plains (the “Optionor”) whereby the Optionor granted the Company the right to acquire up to an 80% interest in the Pine Channel Property (the “Property”). Under the amended terms of the Amendment Agreement, Apogee has been granted an extension on the due date of the CAD $50,000 cash payment and 700,000 common share issuance from December 31st, 2024, to December 31st, 2025, as well as an extension on the required exploration expenditures of $500,000 due by June 30th, 2025 to December 31st, 2025. To fulfill the option to acquire the Property, the Company must incur a total of $2,500,000 in exploration expenditures, pay...

Shareholders to vote on the appointment of the new auditors at the upcoming annual general meeting of shareholders DENVER, June 20, 2025 (GLOBE NEWSWIRE) — Intermap Technologies Corporation (TSX: IMP) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that MNP LLP (“MNP”) have been appointed as auditors of the Company. The board of directors of the Company (the “Board”) approved the appointment of MNP as auditors. KPMG LLP (“KPMG”) were the former auditors of the Company. On May 5, 2025 (the “Resignation Date”), KPMG notified the Company of their decision, at their own initiative, to decline to stand for re-appointment as the Company’s auditors in respect of the financial year ending December 31, 2025. The Company has worked diligently since the Resignation Date...

CALGARY, Alberta, June 20, 2025 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) today announced that, for personal reasons, Peter Dey will be stepping down from the Board of Gran Tierra at the end of June 2025. Peter has agreed to make himself available to consult with the Board as required until the end of 2025 while a search is conducted for a replacement director. “On behalf of the Board of Directors of Gran Tierra, I want to thank Peter for his leadership and guidance since 2015,” said Bob Hodgins, Chairman of Gran Tierra Energy Inc. “We have worked with Peter for almost 15 years across multiple companies and continents. Peter is a distinguished expert in board governance, and his broad commercial background and strategic input have been instrumental in navigating...

VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), announces that it proposes to undertake a non-brokered private placement of up to 10,571,438 units (each, a “Unit”), at a purchase price of $0.35 per Unit, to raise total gross proceeds of up to $3,700,003.30 (the “Placement”). Each Unit will consist of one common share of the Company (each, a “Share”) and one transferable common share purchase warrant (each, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Share at an exercise price of $0.46 for a period of 24 months from the closing date. The Company will use the proceeds from the Placement towards exploration on the Company’s properties and/or for general working capital purposes. The Units will be offered to qualified...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) — Enigmatig Limited (NYSE American: EGG) (“Enigmatig” or the “Company”), an international consultancy firm providing one-stop cross-border licensing solutions and related services, today announced that it has completed its previously announced initial public offering (the “IPO”) and the sole bookrunner, on behalf of the underwriters, has exercised the over-allotment opinion in part to purchase an additional 160,000 shares of common stock from the Company at the IPO price of US$5.00 per share. After giving effect to the exercise of the Over-Allotment Option, the total number of Class A ordinary shares sold by the Company in the Offering increased to 3,005,200 Class A ordinary shares and the gross proceeds increased to US$15,026,000 before deducting underwriting...

LONDON, Ontario, June 20, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that it issued an additional 142,180 common shares and warrants to purchase an additional 71,090 common shares, for total gross proceeds of approximately US$1.2 million, pursuant to D. Boral Capital LLC’s full exercise of its underwriter’s over-allotment option in connection with the Company’s previously announced underwritten U.S. public offering of common shares and accompanying warrants to purchase common shares (“Offering”). The common shares issued pursuant to the over-allotment option...

NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM) today announced the receipt of a warning notification (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has...

WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced that on June 16, 2025 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase 112,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”). The Inducement Grant has a ten-year term and an exercise price per share of $9.97, which is equal to the closing price of Zenas’ common stock on the Grant...

TORONTO, June 20, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has filed a preliminary short form base shelf prospectus (the “Prospectus”) to provide the Company with the flexibility to take advantage of financing opportunities and favourable market conditions, if and when needed, during the 25-month period that the Prospectus, once made final, remains effective (the “Effective Period”). A copy of the Prospectus may be obtained under the Company’s SEDAR+ profile at www.sedarplus.ca. The Prospectus has been filed in each of the provinces and territories in Canada. The Prospectus, when final...

DANVILLE, Calif., June 20, 2025 (GLOBE NEWSWIRE) — Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it filed a supplement to its definitive proxy statement, originally file with the Securities and Exchange Commission on June 10, 2025, to amend the language of the Trust Amendment Proposal. Specifically, the amendment removes the words “up to $55,000 per one-month extension”. As revised, the Trust Amendment Proposal provides that the Company will deposit in to the trust account an amount equal to $0.033 multiplied by the number of ordinary shares sold to the public in the Company’s initial public offering and that remain outstanding after giving effect to the shares that are redeemed in connection with the vote on the Trust Amendment Proposal, for each one-month extension of the deadline to consummate...